Case CCC Scientific Series

These occasional extended conferences will feature recent scientific investigation from our members, starting with presentations by investigators who received pilot funding after competitive peer review by the Cancer Center.

Upcoming Scientific Series Presentations

None scheduled at this time. Check back for updates.

Past Scientific Series Presentations

Date, Time and Location  
Thursday, May 31, 2012
4-6 pm WRB 1-413
Imaging in Cancer

Jim Basilion, PhD

Cheryl Thompson, PhD
Variation in Breast Tissue Gene Expression by Mammographic Density

Chris Flask, PhD
Development of a platform of robust and cost-effective MRI techniques for tissue characterization in preclinical research

Thursday, April 12, 2012
4-6 pm BRB 105
Stem Cells

Alex Huang, MD
Longitudinal tracking of in vivo tumor microenvironment in high definition

Jeongwu Lee, PhD
C-MET signaling in GBM stem cells and treatment resistance

Ofer Reizes, PhD
Obesity tips the scales on breast cancer: a role for the fat hormone leptin in cancer stem cell

Thursday, April 21, 2011
4-6:30 pm WRB 1-413

Anton Gorbachev, PhD
Down-Regulation of CXCL9/Mig Expression in the Tumor Microenvironment as a Result of Immunoediting

Neetu Gupta, PhD
A Novel Signaling Link Between Ezrin and JNK Regulates Antigen-Dependent B Cell Survival

Alex Huang, MD, PhD
Measuring Immune Surveillance in Tissue Microenvironment

Monday, November 8, 2010
4-7 pm WRB 1-413
ACS IRG Pilot Project Awards

Derek Taylor, PhD
Structural and Functional Analysis of Human Telomeres and Telomerase

Ge Jin, PhD
Role of Human beta-Defensin-3 in the Progression of Tumors

David Wald, MD, PhD
ATP Depletion as a Therapeutic Strategy for AML

Monday, August 30, 2010
4-7 pm WRB 1-413
Basic Science of Cancer Pilot Project Awards

Cathleen Carlin, PhD and Zhenghe Wang, PhD
Cross-Talk Between EGFR and PTPN14 During Integrin-Regulated Cell Adhesion: Role for STAT3

Shigemi Matsuyama, PhD and Alex Almasan, PhD
Cell Death Decision Mechanism by the Interaction of Factors Regulating Cell Cycle (CyclinE) and DNA Repair (Ku70)

Saba Valadkhan, PhD and Phil Howe, PhD
Characterization of the Anti-Apoptotic Activity of a TGF-B Responsive Non-Coding RNA

Thursday, January 28, 2010
4-7 pm WRB 1-413
Diet, Obesity and Susceptibility to Colon Cancer

Stephanie Doerner
Diet, Obesity and Susceptibility to Colon Cancer

Cheryl Thompson, PhD
Activation of the PI3K Pathway in Colon and Breast Cancer

Ofer Reizes, PhD
Role of Leptin in Mammary Tumorigenesis

Sanjay Patel, MD
The Effect of Sleep Disturbances on Adipose Tissue Gene Expression

Thursday, November 5, 2009
4-7 pm WRB 1-413
RNA Microanalysis

Timothy W. Nilsen, PhD
RNA Metabolism and Cancer

Saba Valadkhan, MD, PhD
The Human Genome as an RNA Machine

Eain A. Murphy, PhD
How Small RNAs Can Play Big Roles in Viral Disease

Monday, May 11, 2009
4:30-6:30 pm WRB 1-413
American Cancer Society Pilot Project Awards

Patrick Ma, MD
EGFR Mutations and Differential Response to Inhibitors in Leptomeningeal Metastases: Opportunities for Individualized Targeted Therapy in Lung Cancer

Alex Huang, MD, PhD
Role of Tumor Microenvironment on Immune Cell Trafficking and Function in situ

Alan Zhu, PhD
Protein Phosphatase 2A Dephosphorylates Smoothened to Inhibit Hedgehog Signaling

Tuesday, March 24, 2009
4-6 pm WRB 1-413
Transcriptional Regulatory Networks in Breast Cancer: Research Funded by the Cancer Center Breast Cancer Working Group

Ruth Keri, PhD
Forkhead Transcription Factors in Breast Development and Cancer

Monica Montano, PhD
Negative Regulators of Mammary Carcinogenesis

Noa Noy, PhD
Retinoic Acid Signaling in Breast Cancer Development

Mukesh Jain, MD
KLF2 & A Novel Inhibitor of Breast Cancer Development

Julian Kim, MD
KLF-4 as a Regulator of Immunity

Thursday, January 8, 2009
4-6 pm WRB 1-413
Basic Science of Cancer Project Awards

Susann Brady-Kalnay, PhD
Imaging Glioblastomas Using Probes that Detect the Receptor Protein Tyrosine Phosphatase mu

Chris Flask, PhD
Development of PARACEST-MRI Imaging Agents for in vivo Assessment of Autophagy

Yanming Wang, PhD
In vivo Quantification of DNA Damages in Cancer Chemotherapies